Acanthamoeba keratitis: risk factors and outcome.
Hay
J
J
Seal
D V
DV
D015823:Acanthamoeba Keratitis / Q000188:drug therapy*; D000981:Antiprotozoal Agents / Q000627:therapeutic use*; D001550:Benzamidines / Q000627:therapeutic use*; D001645:Biguanides / Q000627:therapeutic use; D006801:Humans
D000981:Antiprotozoal Agents; D001550:Benzamidines; D001645:Biguanides; C031233:polihexanide; C046651:propamidine isethionate